Trend Report: DE&I in Clinical Research: Where we are Today
Explore the state of DE&I in clinical research with survey insights on diversity plans, budgeting efforts, and progress in trial representation.
Explore the state of DE&I in clinical research with survey insights on diversity plans, budgeting efforts, and progress in trial representation.
A phased approach to quality management systems (QMS) ensures quality is embedded at every stage, from discovery to post study.
Discover how Parexel accelerated mRNA study startups with Advarra’s integrated IRB and IBC reviews, achieving rapid timelines and budget goals.
The clinical trial startup process has seen significant shifts over the past five years: growth in decentralized trials, improved technology,
When it comes to clinical development, precision, compliance, and quality assurance are paramount. Like any complex and highly regulated industry,
HRPP staffing is essential for maintaining research ethics, even with sIRB mandates streamlining review processes for multisite studies. Discover key HRPP roles and benefits.
Human research protection programs (HRPPs) play a critical role in protecting the rights, safety, and welfare of research participants. A
Single IRB (sIRB) review streamlines oversight for multisite trials, reducing administrative burdens while ensuring participant protections across all sites.
The clinical research industry is only becoming more complex and competitive as organizations are inundated with multiple trials and tight
Clinical trials involving investigational in vitro diagnostic (IVD) devices are subject to the Food and Drug Administration’s (FDA’s) investigational device
Each clinical trial phase builds on the last, from initial safety to post-market studies, ensuring treatments are safe, effective, and beneficial for patients.
Oncology trials face unique hurdles in innovation, enrollment, and endpoints, requiring strategic planning to address complex study demands and precision needs.